: Charles W. Hewitt, W.P. Andrew Lee, C.R. Gordon
: Charles W. Hewitt, W.P. Andrew Lee
: Transplantation of Composite Tissue Allografts
: Springer-Verlag
: 9780387746821
: 1
: CHF 132.50
:
: Nichtklinische Fächer
: English
: 483
: Wasserzeichen
: PC/MAC/eReader/Tablet
: PDF

This brilliant synthesis summarizes all of the recent accomplishments - as well as the ongoing research - in the field of composite tissue transplantation. It includes sections on hand transplantation and vascularized bone marrow transplantation. The volume focuses on immunology and the biotechnology/bioengineering aspects of transplantation surgery, as those two areas have demonstrated the most growth within the last five years in terms of current research.

Foreword: The Import of Composite Tissue Transplantation6
Preface7
Contents8
Contributors12
Section I18
The Establishment of Composite Tissue Allotransplantion as a Clinical Reality19
1.1 Introduction19
The Evolution of Composite Tissue Allotransplantation: the Twentieth Century Realization of “ Cosmas and Damian”29
2.1 Historical Background29
2.2 Current Status33
2.2.1 Trachea34
2.2.2 Peripheral Nerve34
2.2.3 Flexor Tendon Apparatus35
2.2.4 Vascularized Knee35
2.2.5 Lower Extremity36
2.2.6 Larynx36
2.2.7 Abdominal Wall36
2.2.8 Partial Face37
2.2.9 Complete Face/Scalp37
References38
The Impact of the Discovery of Cyclosporine on Transplantation of Composite Tissue Allografts42
3.1 Introduction42
3.2 History of Composite Transplantation42
3.3 Immunosuppression43
3.4 Cyclosporine: Discovery and Structure44
3.5 Cyclosporine: Mechanism of Action46
3.6 Biologic Effects of Cyclosporine46
References48
The First Limb Transplants with Cyclosporine52
4.1 Introduction52
4.2 The Questions52
4.3 Materials and Methods53
4.4 Cyclosporine and Limb Transplants54
4.5 The Return of Cosmas and Damian54
References55
Section II56
Translational Research in Composite Tissue Allotransplantation57
5.1 Introduction57
5.2 Classification of Human Skin Rejection in CTA58
5.3 Development of a Nonhuman Primate Model for the Study of CTA60
5.3.1 Postoperative Management62
5.3.2 Results64
5.4 Conclusions65
References67
Relative Antigenicity of Allograft Components and Differential Rejection69
6.1 Introduction69
6.2 Components of Vascularized Tissue Allograft70
6.2.1 Skin71
6.2.2 Muscle74
6.2.3 Tendon74
6.2.4 Cartilage75
6.2.5 Bone75
6.2.6 Nerve77
6.2.7 Vessels77
6.3 Discussion78
References80
On the Road to Tolerance Induction in Composite Tissue Allotransplantation84
7.1 Introduction84
7.2 T-Cell Tolerance86
7.3 Regulatory T Cells87
7.4 T Suppressor Cells88
7.5 Pharmacologic Induction Strategies89
7.6 Costimulation Blockade89
7.7 Donor-Specific Transfusions91
7.8 T-Cell Activation91
7.9 Dendritic Cells92
7.10 Microchimerism94
7.11 Mixed Chimerism94
7.12 Conclusion95
References96
Donor-Specific Tolerance102
8.1 Introduction102
8.2 Physiologic Mechanisms of Induction Therapy 103
8.2.1 T Cells103
8.3 Generation of T Regulatory Cells104
8.4 T-Cell Costimulatory Blockade106
8.5 Donor-Specific Transfusion108
8.6 Gene Therapy for Tolerance Induction109
8.6.1 Gene Therapy Vectors110
8.6.2 Chemokine Antagonists111
8.6.3 MHC Molecules112
8.6.4 Immunosuppressive Cytokines112
8.6.5 Blockage of Costimulatory Signals113
8.7 Conclusion114
References114
Immune Tolerance Induction: Basic Concepts for Composite Tissue Allotransplantation119
9.1 The Clinical Problem and Possible Solution119
9.2 Immune Tolerance Definition120
9.3 Immune Mechanisms Implicated in Tolerance121
9.3.1 Central Tolerance121
9.3.2 Peripheral Tolerance122
9.4 Composite Tissue Allograft Rejection125
9.5 Strategies for Tolerance Induction in CTA126
References128
Section III132
Allograft Survival with Calcineurin Inhibitors133
10.1 Introduction133
10.2 Molecular Action of Calcineurin Inhibitors133
10.2.1 Immunosuppression with Calcineurin Inhibitors and Survival of Composite Tissue Allografts in Small Animals134
10.2.2 Immunosuppression with Calcineurin Inhibitors and Survival of Composite Tissue Allografts in Large Animals142
10.2.3 Clinical Applications of Composite Tissue Transplantation and Immunosuppression with Calcineurin Inhibitors145
10.2.4 Short-Term Immunosuppression with Calcineurin Inhibitors and Tolerance Induction in Composite Tissue Allografts145
10.3 Future Solutions156
References156
Long-Term Prevention of Rejection and Combination Drug Therapy162
11.1 Introduction162
11.2 Combination Drug Therapy162
11.3 First Clinical Applications165
11.4 Hand Transplantation167
11.5 Chronic Rejection169
References171
Locoregional Immunosuppression in Composite Tissue Allografting176
12.1 Introduction176